SXL
ARKG icon

Summit X LLC’s ARK Genomic Revolution ETF ARKG Stock Holding History

Summit X LLC’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-6,953
Closed -$311K – 249
2022
Q1 		$311K Sell
6,953
-132
-2% -$6.29K 0.08% 209
2021
Q4 		$436K Sell
7,085
-71
-1% -$4.91K 0.1% 185
2021
Q3 		$534K Buy
7,156
+91
+1% +$7.63K 0.13% 158
2021
Q2 		$655K Buy
7,065
+149
+2% +$12.7K 0.17% 136
2021
Q1 		$614K Buy
6,916
+2,069
+43% +$205K 0.17% 136
2020
Q4 		$456K Buy
4,847
+1,545
+47% +$123K 0.13% 161
2020
Q3 		$2.1K Buy
+3,302
New +$193K 0.03% 184

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Summit X LLC's ARKG Position: Q2 2022 in Review

Summit X LLC sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2022, closing a stake of 6,953 shares — an estimated $311K sold.

Summit X LLC first reported a position in ARKG in Q3 2020 and held it in 7 quarters. The position peaked at $655K in Q2 2021. 333 funds tracked by Wall St. Rank hold ARKG as of Q2 2022.

  • Summit X LLC reported no remaining ARK Genomic Revolution ETF position as of Q2 2022 after selling out during the quarter.
  • Summit X LLC sold 6,953 ARK Genomic Revolution ETF shares in Q2 2022, an estimated $311K.
  • Summit X LLC first reported a position in ARK Genomic Revolution ETF in Q3 2020 and held it in 7 quarters.
  • Summit X LLC's ARK Genomic Revolution ETF position peaked at $655K in Q2 2021.
  • 333 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2022.

Based on Summit X LLC's 13F filing for Q2 2022, filed 12 Aug 2022.